HEBP2-governed glutamine competition between tumor and macrophages dictates immunotherapy efficacy in triple-negative breast cancer
- Journal:
- Cell Metabolism
- Published:
- Affiliations:
- 4
- Authors:
- 13
| Institutions | Authors | Share |
|---|---|---|
| Fudan University Shanghai Cancer Center (FUSCC), China | 0.48 | |
| Shanghai Medical College (SHMC), Fudan University, China | 0.48 | |
| Shanghai Academy of Natural Sciences (SANS), China | 0.02 | |
| Fudan University, China | 0.02 |